Bio-Rad Laboratories (BIO) Beats Q2 Earnings Estimates
Bio-Rad (BIO) delivered earnings and revenue surprises of +11.97% and -0.97%, respectively, for the quarter ended June 2026. Do the…
355,740$
-1,51%
Echtzeit-Aktienkurs Bio-Rad Laboratories Inc.
Bid:
Ask:
Nachrichten zur Bio-Rad Laboratories Inc. Aktie
Bio-Rad Laboratories stock falls on lowered revenue outlook
Bio-Rad Laboratories stock falls on lowered revenue outlook…
Bio-Rad (BIO) Q1 2026 Earnings Transcript
Image source: The Motley Fool.DATEThursday, April 30, 2026 at 5 p.m. ETCall participantsChief Executive Officer — Norman SchwartzPresident and Chief…
Bio-Rad Laboratories (BIO) Lags Q1 Earnings Estimates
Bio-Rad (BIO) delivered earnings and revenue surprises of -31.77% and +1.83%, respectively, for the quarter ended March 2026. Do the…
Biodesix (BDSX) Q4 2025 Earnings Call Transcript
Image source: The Motley Fool.DateFeb. 26, 2026, at 4:30 p.m. ETCall participantsChief Executive Officer — Scott HuttonChief Financial Officer —…
Bio-Rad Laboratories (BIO) Q4 Earnings Miss Estimates
Bio-Rad (BIO) delivered earnings and revenue surprises of -2.34% and +0.01%, respectively, for the quarter ended December 2025. Do the…
Bio-Rad Laboratories (BIO) Q3 Earnings Miss Estimates
Bio-Rad (BIO) delivered earnings and revenue surprises of -1.74% and +0.24%, respectively, for the quarter ended September 2025. Do the…
Bio-Rad Laboratories: Ausrüster im Maschinenraum des Gentest-Booms steht vor der Wende
Nach einem zwischenzeitlichen Hype im Lifestyle-Markt – insbesondere für Herkunftstests – bietet aktuell der medizinische Bereich enorme Wachstumspotenziale für Gentests.…
Earnings Preview: Bio-Rad Laboratories (BIO) Q2 Earnings Expected to Decline
Bio-Rad (BIO) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming…
Bio-Rad Laboratories, Inc. (BIO) Q1 2025 Earnings Call Transcript
…
Bio-Rad Laboratories, Inc. (BIO) Q4 2024 Earnings Call Transcript
…
Bio-Rad Laboratories (BIO) Misses Q4 Earnings and Revenue Estimates
Bio-Rad (BIO) delivered earnings and revenue surprises of -1.02% and 1.07%, respectively, for the quarter ended December 2024. Do the…
Earnings Preview: Bio-Rad Laboratories (BIO) Q4 Earnings Expected to Decline
Bio-Rad (BIO) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming…
Has BioRad Laboratories (BIO) Outpaced Other Medical Stocks This Year?
Here is how Bio-Rad Laboratories (BIO) and Certara, Inc. (CERT) have performed compared to their sector so far this year.…
Know About Index Funds? This Simple Strategy Would Have Beaten the Pros This Year.
2024 isnt over yet, but its on track to be a banner year for the stock market. The S&P 500…
Bio-Rad Laboratories: Overvalued Given Current Growth Prospects
…
Dell, Palantir to join S&P 500 on September 23
Shares of Dell Technologies (DELL) and Palantir Technologies (PLTR) are rallying as they prepare to join the S&P 500 (^GSPC)…
Global Biological Buffers Market Size To Worth USD 1,524.14 Million By 2033 | CAGR of 7.47%
The Global Biological Buffers Market Size was Valued at USD 741.69 Million in 2023 and the Worldwide Biological Buffers Market…
Palantir and Dell surge as they join S&P 500 in latest index reshuffle
American Airlines Group Inc., Etsy Inc. and Bio-Rad Laboratories Inc. are being replaced on the index.…
Global Viral Inactivation Market Size To Worth USD 1915.2 Million By 2033 | CAGR Of 11.35%
The Global Viral Inactivation Market Size was Valued at USD 653.8 Million in 2023 and the Worldwide Viral Inactivation Market…
Global Cancer Biomarkers Market to Surge from USD 22.78 Billion in 2023 to USD 82.66 Billion by 2033, Achieving a CAGR of 13.76%
According to a research report published by Exactitude Consultancy, Companies covered:Abbott Laboratories Inc. - North America, Agilent Technologies Inc. -…
Bio-Rad Laboratories appoints DiVincenzo as COO
…
Global Transfection Technologies Market Size To Worth USD 2.7 Billion By 2033 | CAGR Of 9.39%
The Global Transfection Technologies Market Size was Valued at USD 1.1 Billion in 2023 and the Worldwide Transfection Technologies Market…
Bio-Rad Laboratories, Inc. (BIO) Q2 2024 Earnings Call Transcript
…
Global PCOS Diagnostic Market Size To Exceed USD 6.1 Billion By 2033 | CAGR Of 5.18%
The Global PCOS Diagnostic Market Size was Valued at USD 3.68 Billion in 2023 and the Worldwide PCOS Diagnostic Market…
Global Urinalysis Market Size To Exceed USD 6.76 Billion By 2033 | CAGR of 5.41%
The Global Urinalysis Market Size was Valued at USD 3.99 Billion in 2023 and the Worldwide Urinalysis Market Size is…
Global Fecal Calprotectin Test Market Size To Exceed USD 366.15 Million By 2033 | CAGR of 11.24%
The Global Fecal Calprotectin Test Market Size was Valued at USD 126.15 Million in 2023 and the Worldwide Fecal Calprotectin…
Global Nucleic Acid Isolation & Purification Market Size To Exceed USD 12.3 Billion by 2033 | CAGR Of 8.38%
The Global Nucleic Acid Isolation & Purification Market Size was Valued at USD 5.5 Billion in 2023 and the Worldwide…
Global Cell Lysis and Disruption Market Size to Exceed USD 11.15 Billion By 2033 | CAGR of 8.46%
The Global Cell Lysis & Disruption Market Size was Valued at USD 4.95 Billion in 2023 and the Worldwide Cell…
Bio-Rad Laboratories, Inc. (BIO) Q1 2024 Earnings Call Transcript
…
Kursverluste für den Anteilsschein von Bio-Rad Laboratories (305,7197 €)
Im Minus liegt gegenwärtig der Anteilsschein von Bio-Rad Laboratories . Der jüngste Kurs betrug 329,04 US-Dollar. Die Aktie von Bio-Rad…
Bio-Rad Laboratories names Roop Lakkaraju as new CFO
…
Enzyme-Linked Immunosorbent Assay Market revenue to hit USD 27 Billion by 2036, says Research Nester
Key enzyme-linked immunosorbent assay market players include Thermo Fisher Scientific Inc., PerkinElmer, Inc., Bio-Rad Laboratories, Inc., Merck KGaA, F. Hoffmann-La…